Insmed
INSM
#542
Rank
S$56.38 B
Marketcap
S$264.36
Share price
-0.51%
Change (1 day)
161.42%
Change (1 year)

Insmed (INSM) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$1.83 Billion

According to Insmed's latest financial reports the company's total liabilities are S$1.83 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Insmed - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$2.36 B7.76%
2023-12-31S$2.19 B4.37%
2022-12-31S$2.10 B86.71%
2021-12-31S$1.12 B63.62%
2020-12-31S$0.68 B6.22%
2019-12-31S$0.64 B19.69%
2018-12-31S$0.54 B300.82%
2017-12-31S$0.13 B11.8%
2016-12-31S$0.12 B90.39%
2015-12-31S$63.45 M7.61%
2014-12-31S$58.96 M40.3%
2013-12-31S$42.03 M5.17%
2012-12-31S$39.96 M454.41%
2011-12-31S$7.2 M63.53%
2010-12-31S$4.4 M12.9%
2009-12-31S$3.9 M-63.99%
2008-12-31S$10.84 M-5.96%
2007-12-31S$11.52 M-48.03%
2006-12-31S$22.18 M7.97%
2005-12-31S$20.54 M118.06%
2004-12-31S$9.42 M54.4%
2003-12-31S$6.1 M-27.63%
2002-12-31S$8.43 M-61.76%
2001-12-31S$22.04 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sarepta Therapeutics
SRPT
S$2.81 B 53.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$81.04 B 4,319.05%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
S$48.04 B 2,519.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
S$1.56 B-14.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
S$0.69 B-61.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$9.77 B 433.05%๐Ÿ‡บ๐Ÿ‡ธ USA